CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹1,196 Cr | ₹10,145 Cr | ₹884 Cr | ₹884 Cr |
What is the latest Revenue of CORONA REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,196 Cr |
| Mar2025 | ₹10,145 Cr |
| Mar2024 | ₹884 Cr |
| Mar2023 | ₹884 Cr |
How is Revenue of CORONA REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,196 Cr | -88.21 | |
| Mar2025 | ₹10,145 Cr | 1,047.53 | |
| Mar2024 | ₹884 Cr | 0.00 | |
| Mar2023 | ₹884 Cr | - | |
Compare Revenue of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,598.9 Cr | 6.5% | 3.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 6.5% |
3.6% |
|
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses